Zotefoams (LON:ZTF – Get Free Report)‘s stock had its “buy” rating reiterated by Berenberg Bank in a research note issued on Thursday,London Stock Exchange reports. They presently have a GBX 590 price objective on the stock. Berenberg Bank’s target price indicates a potential upside of 34.53% from the stock’s current price.
Separately, Peel Hunt reiterated a “buy” rating and issued a GBX 550 price objective on shares of Zotefoams in a research note on Wednesday. Three research analysts have rated the stock with a Buy rating, According to MarketBeat, the company has an average rating of “Buy” and an average price target of GBX 605.
Read Our Latest Stock Report on Zotefoams
Zotefoams Price Performance
Zotefoams (LON:ZTF – Get Free Report) last announced its quarterly earnings results on Wednesday, August 5th. The company reported GBX 25.70 EPS for the quarter. Zotefoams had a net margin of 14.28% and a return on equity of 18.25%.
About Zotefoams
Zotefoams plc, together with its subsidiaries, manufactures, distributes, and sells polyolefin block foams in the United Kingdom, rest of Europe, North America, and internationally. The company operates through Polyolefin Foams, High-Performance Products, and MuCell Extrusion LLC segments. It offers AZOTE, a polyolefin foam under the Plastazote, Evazote, and Supazote, AZOTE Adapt brands; and various high-performance foams manufactured from fluoropolymers, engineering polymers, and specialty elastomers under the ZOTEK brand; and Ecozote foam for plastic products that offers circularity and reduce reliance on fossil fuel-derived raw materials.
Further Reading
- Five stocks we like better than Zotefoams
- SpaceX: Love the Company, But the Stock Is a Harder Call
- Ulta’s Growth Is Real, But So Are the Risks
- BWX Technologies Is Turning the AI Power Problem Into a Nuclear Growth Story
- Meta’s Earnings Drop Shows Wall Street Wants More Than Ad Growth
Receive News & Ratings for Zotefoams Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zotefoams and related companies with MarketBeat.com's FREE daily email newsletter.
